Cargando…
Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
The clinical demand for mutation detection within multiple genes from a single tumour sample requires molecular diagnostic laboratories to develop rapid, high-throughput, highly sensitive, accurate and parallel testing within tight budget constraints. To meet this demand, many laboratories employ ne...
Autores principales: | Deans, Zandra C, Costa, Jose Luis, Cree, Ian, Dequeker, Els, Edsjö, Anders, Henderson, Shirley, Hummel, Michael, Ligtenberg, Marjolijn JL, Loddo, Marco, Machado, Jose Carlos, Marchetti, Antonio, Marquis, Katherine, Mason, Joanne, Normanno, Nicola, Rouleau, Etienne, Schuuring, Ed, Snelson, Keeda-Marie, Thunnissen, Erik, Tops, Bastiaan, Williams, Gareth, van Krieken, Han, Hall, Jacqueline A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243883/ https://www.ncbi.nlm.nih.gov/pubmed/27678269 http://dx.doi.org/10.1007/s00428-016-2025-7 |
Ejemplares similares
-
Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey
por: Deans, Zandra C., et al.
Publicado: (2017) -
IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
por: Deans, Zandra C., et al.
Publicado: (2019) -
Guidance for laboratories performing molecular pathology for cancer patients
por: Cree, Ian A, et al.
Publicado: (2014) -
Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)
por: Fenizia, Francesca, et al.
Publicado: (2021) -
External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)